Further to above post, one would suggest that if Keytruda and
Lenvima combo are going to be available at very low cost to
Australian public, then Imugene as an Australian company could
expect to be on Public Pharmaceutical list to treat all cancers,
as a combo treatment. Makes good sense to me anyway
Media Thread, page-9340
-
- There are more pages in this discussion • 5,859 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.002(3.70%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.2¢ | $148.9K | 2.828M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 2436853 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 392814 | 5 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |